These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21611755

  • 1. Rituximab and minimal change nephrotic syndrome: a therapeutic option.
    Takei T, Nitta K.
    Clin Exp Nephrol; 2011 Oct; 15(5):641-647. PubMed ID: 21611755
    [Abstract] [Full Text] [Related]

  • 2. Rituximab as a Therapeutic Option for Steroid-Sensitive Minimal Change Nephrotic Syndrome in Adults.
    Iwabuchi Y, Moriyama T, Itabashi M, Takei T, Nitta K.
    Contrib Nephrol; 2018 Oct; 195():12-19. PubMed ID: 29734146
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.
    Munyentwali H, Bouachi K, Audard V, Remy P, Lang P, Mojaat R, Deschênes G, Ronco PM, Plaisier EM, Dahan KY.
    Kidney Int; 2013 Mar; 83(3):511-6. PubMed ID: 23325085
    [Abstract] [Full Text] [Related]

  • 5. Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.
    Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.
    Nephrol Dial Transplant; 2014 Nov; 29(11):2084-91. PubMed ID: 24920841
    [Abstract] [Full Text] [Related]

  • 6. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
    Gilbert RD, Hulse E, Rigden S.
    Pediatr Nephrol; 2006 Nov; 21(11):1698-700. PubMed ID: 16932900
    [Abstract] [Full Text] [Related]

  • 7. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
    Kronbichler A, Bruchfeld A.
    Nephron Clin Pract; 2014 Nov; 128(3-4):277-82. PubMed ID: 25401966
    [Abstract] [Full Text] [Related]

  • 8. Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome.
    Sawara Y, Itabashi M, Kojima C, Tabata H, Kamei D, Kawanishi K, Moriyama T, Sugiura H, Tsukada M, Takei T, Ogawa T, Yoshida T, Arai J, Uchida K, Tsuchiya K, Nitta K.
    Clin Nephrol; 2009 Jul; 72(1):69-72. PubMed ID: 19640390
    [Abstract] [Full Text] [Related]

  • 9. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment.
    Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K.
    Medicine (Baltimore); 2014 Dec; 93(29):e300. PubMed ID: 25546674
    [Abstract] [Full Text] [Related]

  • 10. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
    Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.
    Pediatr Nephrol; 2010 Mar; 25(3):539-44. PubMed ID: 20049616
    [Abstract] [Full Text] [Related]

  • 11. Rituximab in adult patients with immunosuppressive-dependent minimal change disease.
    Hoxha E, Stahl RA, Harendza S.
    Clin Nephrol; 2011 Aug; 76(2):151-8. PubMed ID: 21762648
    [Abstract] [Full Text] [Related]

  • 12. Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab.
    Fujimoto K, Kagaya Y, Kumano S, Fujii A, Tsuruyama Y, Matsuura T, Yamazaki K, Nomura K, Okada K, Okino K, Adachi H, Furuichi K, Yokoyama H.
    Clin Nephrol; 2021 Jan; 95(1):29-36. PubMed ID: 33074094
    [Abstract] [Full Text] [Related]

  • 13. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.
    Amemiya N, Takei T, Kojima C, Nokiba H, Itabashi M, Nitta K.
    Clin Exp Nephrol; 2011 Dec; 15(6):933-6. PubMed ID: 21823044
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J, Du J, Wang S, Xiao L, Zhao X.
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease.
    Iwabuchi Y, Miyabe Y, Makabe S, Nakano M, Manabe S, Karasawa K, Moriyama T, Nitta K.
    Medicine (Baltimore); 2018 Oct; 97(42):e12704. PubMed ID: 30334956
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.
    Katsuno T, Masuda T, Saito S, Kato N, Ishimoto T, Kato S, Kosugi T, Tsuboi N, Kitamura H, Tsuzuki T, Ito Y, Maruyama S.
    Clin Exp Nephrol; 2019 Feb; 23(2):207-214. PubMed ID: 30121802
    [Abstract] [Full Text] [Related]

  • 17. Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells.
    Webendörfer M, Reinhard L, Stahl RAK, Wiech T, Mittrücker HW, Harendza S, Hoxha E.
    Front Immunol; 2020 Feb; 11():586012. PubMed ID: 33628202
    [Abstract] [Full Text] [Related]

  • 18. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
    Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations.
    François H, Daugas E, Bensman A, Ronco P.
    Am J Kidney Dis; 2007 Jan 04; 49(1):158-61. PubMed ID: 17185157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.